ERBB receptors in developing, dysplastic and malignant oral epithelia

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations

Medicine, Molecular Genetics, Oncology +17

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine · 2006 · 5.1K citations · Full text

Medicine, Oncology, Radiation Oncology +13

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Charles L. Vogel · Journal of Clinical Oncology · 2002 · 3K citations

Medicine, Oncology, Pharmacology +17

International Histological Classification of Tumours

RO Weller · Journal of Clinical Pathology · 1981 · 2K citations · Full text

Veterinary Medicine, Oncology, Pathology +12

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

Thomas Holbro, Roger R. Beerli, Francisca Maurer et al. · Proceedings of the National Academy of Sciences · 2003 · 960 citations · Full text

Life Sciences, Molecular Biology, Oncology +17